Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset.
Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Biousse V, Vignal-Clermont C, Sergott RC, Klopstock T, Sadun AA, Barboni P, DeBusk AA, Girmens JF, Rudolph G, Karanjia R, Taiel M, Blouin L, Smits G, Katz B, Sahel JA; LHON Study Group. Newman NJ, et al. Among authors: rudolph g. Ophthalmology. 2021 May;128(5):649-660. doi: 10.1016/j.ophtha.2020.12.012. Epub 2021 Jan 12. Ophthalmology. 2021. PMID: 33451738 Free article. Clinical Trial.
Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy.
Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, Sadun AA, Klopstock T, Vignal-Clermont C, Sergott RC, Rudolph G, La Morgia C, Karanjia R, Taiel M, Blouin L, Burguière P, Smits G, Chevalier C, Masonson H, Salermo Y, Katz B, Picaud S, Calkins DJ, Sahel JA. Yu-Wai-Man P, et al. Among authors: rudolph g. Sci Transl Med. 2020 Dec 9;12(573):eaaz7423. doi: 10.1126/scitranslmed.aaz7423. Sci Transl Med. 2020. PMID: 33298565 Clinical Trial.
Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
Catarino CB, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, Castillo L, Friedburg C, Halfpenny CA, Lincoln JA, Traber GL, Acaroglu G, Black GCM, Doncel C, Fraser CL, Jakubaszko J, Landau K, Langenegger SJ, Muñoz-Negrete FJ, Newman NJ, Poulton J, Scoppettuolo E, Subramanian P, Toosy AT, Vidal M, Vincent AL, Votruba M, Zarowski M, Zermansky A, Lob F, Rudolph G, Mikazans O, Silva M, Llòria X, Metz G, Klopstock T. Catarino CB, et al. Among authors: rudolph g. J Neuroophthalmol. 2020 Dec;40(4):558-565. doi: 10.1097/WNO.0000000000001023. J Neuroophthalmol. 2020. PMID: 32991388 Free PMC article. Clinical Trial.
A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.
Garip Kuebler A, Halfter K, Reznicek L, Klingenstein A, Priglinger S, Rudolph G, Hintschich C. Garip Kuebler A, et al. Among authors: rudolph g. Graefes Arch Clin Exp Ophthalmol. 2021 Nov;259(11):3421-3426. doi: 10.1007/s00417-021-05227-8. Epub 2021 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 34159407 Free PMC article.
Achromatopsia: Genetics and Gene Therapy.
Michalakis S, Gerhardt M, Rudolph G, Priglinger S, Priglinger C. Michalakis S, et al. Among authors: rudolph g. Mol Diagn Ther. 2022 Jan;26(1):51-59. doi: 10.1007/s40291-021-00565-z. Epub 2021 Dec 3. Mol Diagn Ther. 2022. PMID: 34860352 Free PMC article. Review.
[RPE65-associated retinal dystrophies: gene therapy preserves vision].
Gerhardt MJ, Michalakis S, Rudolph G, Priglinger C, Priglinger SG. Gerhardt MJ, et al. Among authors: rudolph g. MMW Fortschr Med. 2022 Feb;164(Suppl 4):40-41. doi: 10.1007/s15006-022-0765-7. MMW Fortschr Med. 2022. PMID: 35146717 Review. German. No abstract available.
Evaluation of visual evoked potentials in dysthyroid optic neuropathy.
Garip Kübler A, Halfter K, Reznicek L, Klingenstein A, Priglinger S, Rudolph G, Hintschich C. Garip Kübler A, et al. Among authors: rudolph g. Orbit. 2023 Oct;42(5):475-480. doi: 10.1080/01676830.2022.2123929. Epub 2022 Sep 21. Orbit. 2023. PMID: 36128945
Clinical Phenotype and Course of PDE6A-Associated Retinitis Pigmentosa Disease, Characterized in Preparation for a Gene Supplementation Trial.
Kuehlewein L, Zobor D, Andreasson SO, Ayuso C, Banfi S, Bocquet B, Bernd AS, Biskup S, Boon CJF, Downes SM, Fischer MD, Holz FG, Kellner U, Leroy BP, Meunier I, Nasser F, Rosenberg T, Rudolph G, Stingl K, Thiadens AAHJ, Wilhelm B, Wissinger B, Zrenner E, Kohl S, Weisschuh N; RD-CURE Consortium. Kuehlewein L, et al. Among authors: rudolph g. JAMA Ophthalmol. 2020 Dec 1;138(12):1241-1250. doi: 10.1001/jamaophthalmol.2020.4206. JAMA Ophthalmol. 2020. PMID: 33057649 Free PMC article.
A tourist with dengue fever and visual loss.
Haritoglou C, Dotse SD, Rudolph G, Stephan CM, Thurau SR, Klauss V. Haritoglou C, et al. Among authors: rudolph g. Lancet. 2002 Oct 5;360(9339):1070. doi: 10.1016/s0140-6736(02)11145-7. Lancet. 2002. PMID: 12383989 No abstract available.
331 results